Brief: Aptose Biosciences Reports Qtrly Loss Per Share $0.17
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL
YEAR 2020
* APTOSE BIOSCIENCES INC - ANNOUNCES RESIGNATION OF CFO
GREGORY
CHOW
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.17
* APTOSE BIOSCIENCES INC - TOTAL CASH AND CASH EQUIVALENTS
AND
INVESTMENTS AS OF DECEMBER 31, 2020 WERE $122.4 MILLION
* APTOSE BIOSCIENCES - EXPECTS CASH ON HAND, AVAILABLE
CAPITAL
PROVIDE CO WITH SUFFICIENT RESOURCES TO FUND OPERATIONS INTO H1
2023
Source text for Eikon: ID:nGNXbCp3WK
Further company coverage: APS.TO
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting